Xtant Medical Holdings (XTNT) Net Income towards Common Stockholders Growth (5y) (2015 - 2025)
Xtant Medical Holdings (XTNT) Net Income towards Common Stockholders Growth (5y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn |
| 10 | Xtant Medical Holdings | 46.72 Mn | 29.11 Mn | 17.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 15.78% |
| Sep 30, 2025 | 24.25% |
| Jun 30, 2025 | 28.04% |
| Mar 31, 2025 | 15.14% |
| Dec 31, 2024 | -78.07% |
| Sep 30, 2024 | -21.74% |
| Jun 30, 2024 | -14.77% |
| Mar 31, 2024 | -9.47% |
| Dec 31, 2023 | 35.76% |
| Sep 30, 2023 | 37.57% |
| Jun 30, 2023 | 15.23% |
| Mar 31, 2023 | 16.93% |
| Dec 31, 2022 | 30.76% |
| Sep 30, 2022 | 33.55% |
| Jun 30, 2022 | 30.86% |
| Mar 31, 2022 | 32.67% |
| Dec 31, 2021 | 32.29% |
| Sep 30, 2021 | 37.89% |
| Jun 30, 2021 | 48.18% |
| Mar 31, 2021 | 66.55% |